Target intelligence / Profile preview

Bacterial cell wall and biofilm matrix components

Molecular classification
Other
01

Overview

The bacterial cell wall and biofilm matrix components constitute the primary structural and protective barriers of bacterial cells and communities. The cell wall, characterized by a peptidoglycan layer in both Gram-positive and Gram-negative bacteria, maintains cell shape and prevents osmotic lysis, while the biofilm matrix—a complex mixture of polysaccharides, proteins, and extracellular DNA (eDNA)—encases bacteria in a resilient, multicellular structure. These components are critical for bacterial virulence, as they facilitate adhesion to host surfaces and provide a shield against host immune defenses and environmental stressors. In clinical settings, the biofilm matrix is a major contributor to antibiotic tolerance, often rendering standard treatments 10 to 1000 times less effective by physically blocking drug penetration and harboring dormant persister cells. Therapeutic interventions targeting these structures include traditional antibiotics that inhibit cell wall synthesis, such as beta-lactams and glycopeptides, and emerging anti-biofilm agents designed to enzymatically degrade the extracellular matrix. Understanding the interplay between these components is essential for developing strategies to combat chronic infections and the rising threat of antimicrobial resistance.

Other names
Bacterial cell envelopeExtracellular polymeric substances (EPS)Biofilm extracellular matrixPeptidoglycan layerBacterial cell wallMureinLipopolysaccharide (LPS)Teichoic acid
02

Mechanism of action

Inhibition of peptidoglycan synthesis, disruption of the bacterial outer membrane, and enzymatic degradation of the biofilm extracellular matrix.

03

Biological functions

Structural integrityProtectionAdhesionBarrier functionCellular communication
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistance developmentDisruption of commensal microbiomeEndotoxin release (LPS) leading to systemic inflammationPoor drug penetration into deep biofilm layers
06

Interacting drugs

Penicillin

9 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA) levelsAlginate productionBiofilm-associated proteins (BAPs)ProcalcitoninC-reactive protein (CRP)

Beyond the preview

Go deeper on Bacterial cell wall and biofilm matrix components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall and biofilm matrix components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call